A groundbreaking study by researchers from RMIT University in Australia and Indian institutions has unveiled a novel ...

Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

Prostate cancer is the second-leading cause of cancer death among American men. With 1 in 8 facing this diagnosis over his ...

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

When Doug was first diagnosed with prostate cancer, sex was the last thing on his mind. Like anyone facing a cancer diagnosis ...

Both rare and aggressive, triple-negative breast cancer accounts for 10-15% of all breast cancers. Dr. Bhardwaj says, “TNBC ...

Initial research suggests this saliva test can be more accurate at identifying men who are at high risk of cancer than the prostate-specific antigen blood test.

Discover a recent clinical trial that explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with ...

Early cancer detection often marks the difference between successful treatment and grave outcomes. Understanding warning ...

AstraZeneca PLC on Monday said its Truqap combination in a type of prostate cancer showed a statistically significant improvement in a form of progression-free survival. The Cambridge, England-based ...

Scientists at Weill Cornell Medicine have uncovered a critical mechanism driving the growth of treatment-resistant prostate ...

Chunhui Han, PhD, discusses the potential feasibility of the integration of Gallium 68 PSMA-11 in biology-guided radiotherapy ...